Research graph
References from Impact of a recent cancer diagnosis on bleeding risk after myocardial infarction. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1161/circulationaha.115.020406
10.1161/circulationaha.115.020406 · External reference
10.1007/s11912-010-0139-7
10.1007/s11912-010-0139-7 · External reference
Unresolved reference
External reference
10.2337/dc10-0666
10.2337/dc10-0666 · External reference
10.1016/s1470-2045(19)30456-5
10.1016/s1470-2045(19)30456-5 · External reference
10.1093/ageing/aft201
10.1093/ageing/aft201 · External reference
Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: JACC: CardioOncology State-of-the-Art Review
10.1016/j.jaccao.2023.05.008 · 2023 · External reference
Characteristics, Management, and Outcomes of Acute Coronary Syndrome Patients with Cancer
10.3390/jcm9113642 · 2020 · External reference
10.1001/jama.2016.3775
10.1001/jama.2016.3775 · External reference
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
10.1016/s0140-6736(17)30397-5 · 2017 · External reference
10.1016/j.jacc.2017.06.047
10.1016/j.jacc.2017.06.047 · External reference
Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions
10.1016/j.ijcard.2021.07.054 · 2021 · External reference
Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA
10.1093/eurheartj/ehz851 · 2020 · External reference
10.1093/eurheartj/ehz372
10.1093/eurheartj/ehz372 · External reference
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
10.1186/s12885-019-5354-5 · 2019 · External reference
The Role of Platelets in Cancer-Related Bleeding Risk: A Systematic Review
10.1055/s-0039-3402429 · 2020 · External reference
Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism
10.1016/j.amjmed.2018.04.037 · 2018 · External reference
Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA
10.1093/eurheartj/ehaa1032 · 2021 · External reference
10.1093/eurheartj/ehac244
10.1093/eurheartj/ehac244 · External reference
10.1093/eurheartj/ehad191
10.1093/eurheartj/ehad191 · External reference
Data Resource Profile: The Virtual Cardio-Oncology Research Initiative (VICORI) linking national English cancer registration and cardiovascular audits
10.1093/ije/dyab082 · 2022 · External reference
10.1093/ije/dyz076
10.1093/ije/dyz076 · External reference
10.1093/ehjqcco/qcz052
10.1093/ehjqcco/qcz052 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Case-ascertainment of acute myocardial infarction hospitalizations in cancer patients: a cohort study using English linked electronic health data
10.1093/ehjqcco/qcab045 · 2022 · External reference
Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies: A National Registry Dataset Analysis
10.1016/j.jaccao.2022.03.004 · 2022 · External reference
The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
10.1136/bmj.h246 · 2015 · External reference
Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: Findings from the Norwegian Coronary Stent Trial (NORSTENT)
10.1371/journal.pone.0247358 · 2021 · External reference
10.1001/jama.2015.517
10.1001/jama.2015.517 · External reference
Incidence, Risk Factors, and Clinical Effects of Recurrent Diverticular Hemorrhage: A Large Cohort Study
10.1053/j.gastro.2018.07.026 · 2018 · External reference
Rationale, Design and Methods of the Prospective Record of the Use of Dabigatran in Patients with Acute Stroke or TIA (PRODAST) Study
10.1177/23969873211060219 · 2021 · External reference
10.1177/0272989x09341755
10.1177/0272989x09341755 · External reference
10.1111/j.1467-6419.2007.00527.x
10.1111/j.1467-6419.2007.00527.x · External reference
Balance diagnostics after propensity score matching
10.21037/atm.2018.12.10 · 2019 · External reference
10.1002/sim.1203
10.1002/sim.1203 · External reference
10.1016/j.jclinepi.2007.11.008
10.1016/j.jclinepi.2007.11.008 · External reference
Unresolved reference
External reference
Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States
10.1093/eurheartj/ehy769 · 2019 · External reference
10.1016/j.amjcard.2013.08.019
10.1016/j.amjcard.2013.08.019 · External reference
Temporal trends and outcomes of acute myocardial infarction in patients with cancer
10.21037/atm.2017.11.29 · 2017 · External reference
Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis
2021 · External reference
Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy
2018 · External reference
Risk Burden of Cancer in Patients Treated With Abbreviated Dual Antiplatelet Therapy After PCI: Analysis of Multicenter Controlled High-Bleeding Risk Trials
10.1161/circinterventions.122.013000 · 2024 · External reference
Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary Intervention
10.1016/j.jaccao.2019.11.001 · 2019 · External reference
